Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children.

Vanessa Franziska SchmidtÖzlem CangirLutz MeyerConstantin GoldannSusanne HengstRichard BrillSusanne von der HeydtMilton WanerDaniel Puhr-WesterheideOsman ÖcalMuzaffer Reha ÜmütlüNabeel MansourJan RudolphAlena SintFlorian ObereisenbuchnerBeate HäberleJens RickeMax SeidenstickerWalter A WohlgemuthMoritz Wildgruber

Published in: European radiology (2024)

Bleomycin electrosclerotherapy is a safe and effective approach and therapy should not be restricted to adults due to good clinical outcomes in children.

Keyphrases

young adults
pulmonary fibrosis
stem cells
cell therapy